Moreover, the importance of ARG1 and AGMAT expression in HCC patients is underscored by the finding that loss of ARG1 and/or AGMAT is associated with reduced survival based on a TCGA liver cancer dataset (Figures 7E, S7G, and S7H). This evidence concerns the gene ARG1 and hepatocellular carcinoma.